Cargando…
Preoperative MRI-radiomics features improve prediction of survival in glioblastoma patients over MGMT methylation status alone
BACKGROUND: Glioblastoma (GBM) is the most common malignant central nervous system tumor, and MGMT promoter hypermethylation in this tumor has been shown to be associated with better prognosis. We evaluated the capacity of radiomics features to add complementary information to MGMT status, to improv...
Autores principales: | Tixier, Florent, Um, Hyemin, Bermudez, Dalton, Iyer, Aditi, Apte, Aditya, Graham, Maya S., Nevel, Kathryn S., Deasy, Joseph O., Young, Robert J., Veeraraghavan, Harini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363013/ https://www.ncbi.nlm.nih.gov/pubmed/30774763 http://dx.doi.org/10.18632/oncotarget.26578 |
Ejemplares similares
-
Radiomic Analysis to Predict Histopathologically Confirmed Pseudoprogression in Glioblastoma Patients
por: McKenney, Anna Sophia, et al.
Publicado: (2022) -
Reproducibility of radiomic features using network analysis and its application in Wasserstein k-means clustering
por: Oh, Jung Hun, et al.
Publicado: (2021) -
Radiomics and MGMT promoter methylation for prognostication of newly diagnosed glioblastoma
por: Sasaki, Takahiro, et al.
Publicado: (2019) -
Association between MGMT Enhancer Methylation and MGMT Promoter Methylation, MGMT Protein Expression, and Overall Survival in Glioblastoma
por: Zappe, Katja, et al.
Publicado: (2023) -
A ”Clickable” Probe for Active MGMT in Glioblastoma Demonstrates Two Discrete Populations of MGMT
por: Raghavan, Sudhir, et al.
Publicado: (2020)